Shati, A.A.; Maarouf, A.; Dawood, A.F.; Bayoumy, N.M.; Alqahtani, Y.A.; A. Eid, R.; Alqahtani, S.M.; Abd Ellatif, M.; Al-Ani, B.; Albawardi, A.
Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus: Metformin Inhibits Femoral Artery Ultrastructural Alterations as well as Vascular Tissue Levels of AGEs/ET-1 Axis-Mediated Inflammation and Modulation of Vascular iNOS and eNOS Expression. Biomedicines 2023, 11, 361.
https://doi.org/10.3390/biomedicines11020361
AMA Style
Shati AA, Maarouf A, Dawood AF, Bayoumy NM, Alqahtani YA, A. Eid R, Alqahtani SM, Abd Ellatif M, Al-Ani B, Albawardi A.
Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus: Metformin Inhibits Femoral Artery Ultrastructural Alterations as well as Vascular Tissue Levels of AGEs/ET-1 Axis-Mediated Inflammation and Modulation of Vascular iNOS and eNOS Expression. Biomedicines. 2023; 11(2):361.
https://doi.org/10.3390/biomedicines11020361
Chicago/Turabian Style
Shati, Ayed A., Amro Maarouf, Amal F. Dawood, Nervana M. Bayoumy, Youssef A. Alqahtani, Refaat A. Eid, Saeed M. Alqahtani, Mohamed Abd Ellatif, Bahjat Al-Ani, and Alia Albawardi.
2023. "Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus: Metformin Inhibits Femoral Artery Ultrastructural Alterations as well as Vascular Tissue Levels of AGEs/ET-1 Axis-Mediated Inflammation and Modulation of Vascular iNOS and eNOS Expression" Biomedicines 11, no. 2: 361.
https://doi.org/10.3390/biomedicines11020361
APA Style
Shati, A. A., Maarouf, A., Dawood, A. F., Bayoumy, N. M., Alqahtani, Y. A., A. Eid, R., Alqahtani, S. M., Abd Ellatif, M., Al-Ani, B., & Albawardi, A.
(2023). Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus: Metformin Inhibits Femoral Artery Ultrastructural Alterations as well as Vascular Tissue Levels of AGEs/ET-1 Axis-Mediated Inflammation and Modulation of Vascular iNOS and eNOS Expression. Biomedicines, 11(2), 361.
https://doi.org/10.3390/biomedicines11020361
